Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

Type 2 diabetes , chronic kidney disease , and heart disease consist of a range of risk factors. For example, hyperglycemia, ...

aSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China bJiangsu Province Engineering Research Center of TCM Intelligence Health Service, ...

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Clash over calls to prescribe weight loss drugs for life - despite concerns over side effects, and dramatic weight regain ...

According to the Daily Mail, patients who take the weight-loss shots were twice as likely to suffer from a serious ...

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...

Nearly 16 million Americans have the most deadly type of liver disease - metabolic dysfunction-associated steatohepatitis ...

Dr Sof Andrikopoulos explains why moderation is key to prevention—and how new therapies are changing the game in diabetes ...